Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044429 · ClinicalTrials.gov registry record · Phase 4
Postoperative Pain Control Following Renal Transplant
A Phase 4 study, sponsored by George Washington University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT05044429 is a Phase 4 study that was terminated before completion, run by George Washington University. The registered enrollment target is 31 participants.
The verdict
NCT05044429, a Phase 4 study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study aims to compare the effectiveness of a regional anesthetic block vs systemic intravenous (IV) lidocaine in controlling post-operative pain in kidney transplantation patients. Regional anesthetic blocks and lidocaine infusions are effective alternatives to opioid medications and are already in use at many institutions. However, there has been no prospective study comparing their effectiveness when used in conjunction with the current standard of care patient controlled analgesia (PCA) pumps. This study is a prospective, randomized evaluation of both treatment methods.
Interventions
- DRUG Intravenous Lidocaine
- DRUG Transversus abdominis plane (TAP) block
- DRUG Quadratus Lumborum (QL) Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2023-11-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05044429
The ClinicalTrials.gov registry entry for NCT05044429 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intravenous Lidocaine is the first listed.
NCT05044429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05044429 about?
NCT05044429 is a clinical study titled "Postoperative Pain Control Following Renal Transplant". This study aims to compare the effectiveness of a regional anesthetic block vs systemic intravenous (IV) lidocaine in controlling post-operative pain in kidney transplantation patients. Regional anesthetic blocks and lidocaine infusions are effective alternatives to opioid medications and are alread...
What is the current status of trial NCT05044429?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2021-03-16. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT05044429?
The interventions under investigation include: Intravenous Lidocaine (DRUG), Transversus abdominis plane (TAP) block (DRUG), Quadratus Lumborum (QL) Block (DRUG).
Who is sponsoring clinical trial NCT05044429?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.